Prion diseases are disorders of protein conformation that produce neurodegeneration in humans and animals. Studies of transgenic (Tg) mice indicate that a factor designated protein X is involved in the conversion of the normal cellular prion protein (PrP C ) into the scrapie isoform (PrP Sc ); protein X appears to interact with PrP C but not with PrP Sc . To search for PrP C binding proteins, we fused PrP with alkaline phosphatase (AP) to produce a soluble, secreted probe. PrP-AP was used to screen a lgt11 mouse brain cDNA library, and six clones were isolated. Four cDNAs are novel while two clones are fragments of Nrf2 (NF-E2 related factor 2) transcription factor and Aplp1 (amyloid precursor-like protein 1). The observation that PrP binds to a member of the APP (amyloid precursor protein) gene family is intriguing, in light of possible relevance to Alzheimer's disease. Four of the isolated clones are expressed preferentially in the mouse brain and encode a similar motif. r 1997 Academic Press
INTRODUCTION
Prion diseases are lethal, degenerative disorders of the central nervous system (CNS). The scrapie prion particle is composed of an aberrant isoform of the prion protein, PrP Sc , which is derived from its normal cellular isoform PrP C by a posttranslational process (Borchelt et al., 1990) . So far, the only identified difference between the two isoforms is conformational. PrP C has a high a-helix content and is devoid of b-sheet PrP C is a sialoglycoprotein, linked to the cell surface by a glycosyl-phosphatidylinositol (GPI) anchor (Endo et al., 1989; Stahl et al., 1987) . In scrapie-infected neuroblastoma (ScN2a) cells, the majority of the membrane-bound PrP C molecules are internalized and degraded (Caughey et al., 1989) while only a small fraction (,5%) is converted into PrP Sc , possibly in cholesterol-rich microdomains (Borchelt et al., 1990; Taraboulos et al., 1995) .
